Washington: Google's Life Sciences division, which is now a subsidiary of the much-talked about Alphabet, is developing a bandage-sized, cloud-connected sensor to help people monitor their glucose levels.
The product is being developed in partnership with DexCom, a California-based company known for its diabetes-management devices, reports the Verge.
It is said that DexCom will be be building the sensors, while Life Sciences will be handling the miniaturization.
The companies claimed that the new device, which is being designed for use with both type 1 and type 2 diabetes, will be low cost and disposable, small, connected and able to provide real-time glucose levels.
“We're committed to developing new technologies that will help move health care from reactive to proactive,” Andrew Conrad, head of the life sciences team at Google, said in a statement released by the two companies.
The products developed through this partnership will be sold exclusively by DexCom.
Life Science's partnership with DexCom is one of two big deals it's made for glucose monitors. Last year, it made a deal with the pharmaceutical company Novartis to commercialize contact lenses that can track glucose levels.
Life Sciences has been working on a number of projects to help people with diabetes.